April 8, 2026 BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
April 8, 2026 New Era Energy & Digital Closes Multi-Tranche $290 Million Senior Secured Term Loan Credit Facility with Macquarie Group to Finance Texas Critical Data Center Flagship Project
